David Benshoof KleinCo Founder

United States - New York, New York,

David Benshoof Klein is a healthcare investor and entrepreneur with over 20 years life science industry experience; he has played key roles in founding, financing and operating more than 10 life science companies. In 2012, Mr. Klein co-founded Click Therapeutics which develops and commercializes software as medical treatments: Digital Therapeutics™. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click is also progressing a broad pipeline of prescription Digital Therapeutics across a variety of high-burden therapeutic areas, including Major Depressive Disorder, Schizophrenia, Acute Coronary Syndrome, Migraine, Chronic Pain, Insomnia, COPD, Obesity, and more. He formerly served as Managing Director at Opus Point Partners, senior consultant to Pfizer, and strategic advisor to numerous publicly traded and privately held life science companies. Mr. Klein has been Guest Faculty at Columbia University’s Biotechnology Program, Columbia Business School, and NYU Stern School of Business. Mr. Klein holds a B.A. from Brandeis University, and was recognized by Goldman Sachs in 2019 as one of the 100 most intriguing entrepreneurs at its annual Builders & Innovators conference. A native New Yorker, Mr. Klein is an avid art enthusiast and is co-founder of Eli Klein Gallery, America’s leading Chinese contemporary art gallery.